Immunodeficiency
📧 Sign up to get email alerts when something new happens for Immunodeficiency.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-12-02Clinical Trial Update: Multicenter Study of Long-Term Clinical Outcomes of Subcutaneous Immune Globulin IgPro20 in Subjects With Primary Immunodeficiency (Japan Study) [Phase 3]
This update reports long-term clinical outcomes from a Phase 3, multicenter study of subcutaneous immune globulin IgPro20 in Japanese subjec…
-
CLINICAL_TRIALS trial_result · 2014-08-13Clinical Trial Update: Reduced Intensity Conditioning for Umbilical Cord Blood Transplant in Pediatric Patients With Non-Malignant Disorders [Phase 1]
Clinical trial update on reduced intensity conditioning for umbilical cord blood transplantation in pediatric patients with non-malignant di…
-
CLINICAL_TRIALS trial_result · 2014-08-06Clinical Trial Update: Evaluating Whole Foods Supplementation on Cognition [NA]
This clinical trial evaluating whole foods supplementation for cognition has completed; no results are disclosed in the update.
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Safety Study of Subcutaneous Ig NextGen 16% in Patients With Primary Immunodeficiency [Phase 3]
This update reports the completion of a Phase 3 safety study evaluating subcutaneous immunoglobulin NextGen 16% in patients with primary imm…
-
CLINICAL_TRIALS trial_result · 2013-02-04Clinical Trial Update: Effect of Ranitidine on Hyper-IgE Recurrent Infection (Job's) Syndrome [Phase 2]
A Phase 2 trial evaluating ranitidine for JOB's syndrome (Hyper-IgE recurrent infection syndrome) was terminated; results were posted in 201…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-01-25Clinical Trial Update: Study of Subcutaneous Immunoglobulin in Patients With PID Requiring IgG Replacement Therapy [Phase 3]
Phase 3 trial update on subcutaneous immunoglobulin for patients with primary immunodeficiency requiring IgG replacement; results have been …
-
CLINICAL_TRIALS trial_result · 2013-01-25Clinical Trial Update: Extension Study of Subcutaneous Immunoglobulin Human in Patients With Primary Immunodeficiency (PID) [Phase 3]
This Phase 3 extension study of subcutaneous immunoglobulin in patients with primary immunodeficiency has completed, and results were posted…
-
CLINICAL_TRIALS trial_result · 2013-01-25Clinical Trial Update: Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (EU Extension Study) [Phase 3]
Phase 3 EU extension study evaluating subcutaneous immunoglobulin for IgG replacement in patients with primary immunodeficiency; CSL Behring…
-
CLINICAL_TRIALS trial_result · 2012-12-18Clinical Trial Update: A Trial of the Pharmacokinetics, Safety, and Tolerability of Subcutaneous Gamunex® in Primary Immunodeficiency [Phase 2]
Phase 2 trial evaluating the pharmacokinetics, safety, and tolerability of subcutaneous Gamunex in patients with primary immunodeficiency; r…
-
CLINICAL_TRIALS trial_result · 2012-06-07Clinical Trial Update: Subcutaneous Ig NextGen 16% in PID Patients [Phase 3]
Phase 3 trial evaluating Subcutaneous Immunoglobulin NextGen 16% in primary immunodeficiency has completed. The update notes completion but …
-
CLINICAL_TRIALS trial_result · 2012-04-05Clinical Trial Update: Study of Vitamin D3 Substitution to Patients With Primary Immunodeficiency [Phase 1, Phase 2]
A phase 1/2 clinical trial studying Vitamin D3 substitution in patients with primary immunodeficiency completed its Phase 1 and Phase 2 port…
-
CLINICAL_TRIALS trial_result · 2010-08-24Clinical Trial Update: Emergency Use of Adoptive Immunotherapy With CMV-Specific T Cells After Donor Bone Marrow Transplant of an Infant With Immunodeficiency Syndrome and CMV Infection
A clinical trial update describes emergency use of adoptive CMV-specific T cell therapy following donor bone marrow transplant in an infant …
-
CLINICAL_TRIALS trial_result · 2010-01-28Clinical Trial Update: Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases. [Phase 3]
Phase 3 study evaluating the efficacy, safety, and pharmacokinetics of Gammaplex in primary immunodeficiency diseases completed with results…
-
CLINICAL_TRIALS trial_result · 2008-03-05Clinical Trial Update: Studies of the Immune Response in Normal Subjects and Patients With Disorders of the Immune System
A completed clinical trial sponsored by the National Cancer Institute studied immune responses in healthy subjects and in patients with immu…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: In Vitro Studies of Immunological and Stem Cell Function in Peripheral Blood Mononuclear Cells in Patients
A completed clinical trial update detailing in vitro investigations of immunological and stem cell function in peripheral blood mononuclear …
-
CLINICAL_TRIALS trial_result · 2007-05-24Clinical Trial Update: Randomized Study of Two Doses of Oral Valacyclovir in Immunocompromised Patients With Uncomplicated Herpes Zoster [NA]
A completed randomized trial compared two oral doses of valacyclovir in immunocompromised patients with uncomplicated herpes zoster.